1405 ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY

Pawlotsky, J.-M.; Sarin, S.K.; Foster, G.; Peng, C.-Y.; Rasenack, J.; Flisiak, R.; Piratvisuth, T.; Wedemeyer, H.; Chuang, W.-L.; Zhang, W.M.; Naoumov, N.V.

期刊名称Journal of Hepatology
作者Pawlotsky, J.-M.; Sarin, S.K.; Foster, G.; Peng, C.-Y.; Rasenack, J.; Flisiak, R.; Piratvisuth, T.; Wedemeyer, H.; Chuang, W.-L.; Zhang, W.M.; Naoumov, N.V.
卷第56卷
印刷ISSN0168-8278
文件大小58.62KB
发表时间2012-4
DOI10.1016/S0168-8278(12)61416-0

发现好书期刊，享受阅读乐趣

1405 ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY